Rybelsus costs as little as $25 with commercial coverage[2]. That is the only price its maker’s savings page prints[2]. There is no self-pay figure on it.
Rybelsus is a daily semaglutide tablet from Novo Nordisk. It comes in 3 mg, 7 mg, 14 mg[1]. It is labeled for type 2 diabetes[1].
| Tablet | Strengths | Self-pay per bottle | With commercial coverage |
|---|---|---|---|
| Rybelsus | 3 mg, 7 mg, 14 mg | Not published | As little as $25 |
| Ozempic pill | 1.5 mg, 4 mg, 9 mg | $149–$299 | As little as $25 |
Whether a plan pays is its own question. See does insurance cover Ozempic.
The savings card
At 7 mg or 14 mg, the card covers a 1-, 2- or 3-month fill[2]. At 3 mg, it runs month by month[2].
Savings cap at $100 a month[2]. The caps are $200 for two months and $300 for three[2].
It is for commercially insured patients whose plan covers Rybelsus[2]. No coverage, no card.
No coverage: the Ozempic pill
Novo Nordisk does print a cash price for its other tablet. The Ozempic pill costs $149 to $299 a bottle of 30[3].
Rybelsus and the Ozempic pill share one label[1]. The Ozempic pill is a new formulation, sold at 1.5 mg, 4 mg, 9 mg[1]. Rybelsus bottles also hold 30 tablets[1].
The full Ozempic ladder is in Ozempic cost. The Wegovy tablet, labeled for weight, is in Wegovy pill cost.
With Medicare
Part D plans list oral semaglutide widely. In the third quarter of 2020, 40.3% of plans listed it[6]. By the same quarter of 2024, 91.8% did[6]. By then 83.0% of those plans required prior authorization[6].
CMS negotiated a Medicare price for Ozempic, Rybelsus and Wegovy together[5]. It takes effect January 1, 2027[5]. Part D enrollees cannot use the maker’s copay cards. See does Medicare cover Ozempic.
What the price pays for
SOUL tested oral semaglutide, up to 14 mg, against placebo[4]. It enrolled 9,650 people aged 50 or older with type 2 diabetes and heart or kidney disease[4].
Major heart events hit 12.0% on semaglutide and 13.8% on placebo[4]. The hazard ratio was 0.86 (95% CI 0.77 to 0.96)[4]. Median follow-up was 49.5 months[4]. Novo Nordisk funded it[4].
The label now lists heart-risk reduction in that group[1].
Against compounded semaglutide
Compounded semaglutide is an injection, not a tablet. It is not FDA-approved. Seller prices are on the semaglutide price board, and the all-in board adds the fees. To test a quote, use the seller price check.
Before paying
- Does your plan cover Rybelsus, and with prior authorization?
- Is your prescription 3 mg, or 7 mg or 14 mg?
- If paying cash, will your prescriber write the Ozempic pill instead?
- Does the card cover your whole copay, or leave a balance above the cap?